Sanofi weighs takeover of US drugmaker Insmed, Bloomberg News reports
Sanofi is reportedly considering an acquisition of US drugmaker Insmed, sending Insmed's shares up 16%. Deliberations are ongoing, with any potential deal expected to take weeks to finalize.
reuters · 2026-11-19 07:18 UTC